Key Takeaways
- • NYU Stern's Center for Business & Human Rights released a report documenting private equity's negative impact on healthcare quality, citing hospital closures, reduced staffing, and compromised services as persistent problems linked to PE ownership.
- • Private equity firms have deployed over $1 trillion in debt-financed healthcare deals over the past decade, with PE-backed healthcare companies carrying average debt-to-cash flow ratios of 7.1—significantly above the 4.0 threshold regulators consider high and well above the 3.0 average for public healthcare companies.
- • Between 2023 and mid-2024, 26 large PE-backed healthcare companies filed for bankruptcy; when including smaller portfolio companies, the total reached 34 bankruptcies in 2023 alone, underscoring the financial instability endemic to leveraged healthcare acquisitions.
- • Sale-leaseback transactions, a standard PE strategy, force healthcare companies to sell owned properties and lease them back, amplifying vulnerability to downturns and typically triggering workforce reductions that directly compromise patient care quality.
- • The report calls for regulatory reforms to govern PE investing practices in healthcare while acknowledging that PE capital and strategic expertise can benefit the sector—advocating for balance rather than elimination of private equity involvement.
Summary
A comprehensive report from NYU Stern's Center for Business & Human Rights documents systemic risks posed by private equity ownership in healthcare, calling for targeted reforms to protect care quality and financial stability. Released in March 2026, the report synthesizes evidence of PE-driven hospital closures, staffing reductions, and service degradation that have accumulated over recent years, establishing a direct causal link between leverage-heavy acquisition models and deteriorating healthcare outcomes.
The scale of PE capital deployment in healthcare underscores the sector's systemic exposure. Private equity firms have invested over $1 trillion through debt-financed deals in the past decade alone, positioning PE as a material force across hospital networks, physician practices, and ancillary healthcare services. However, the financing structures underlying these transactions create acute vulnerabilities. PE-backed healthcare companies carry average debt-to-cash flow ratios of 7.1—well above the 4.0 threshold financial regulators designate as problematic—compared to 3.0 for publicly traded healthcare companies. This leverage differential directly constrains operational flexibility during economic downturns or unexpected cost pressures.
Bankruptcy rates underscore the financial fragility these structures create. Between 2023 and mid-2024, 26 large PE-backed healthcare firms filed for bankruptcy; including smaller portfolio companies, the total reached 34 healthcare bankruptcies in 2023. These failures often trigger cascading reductions in clinical staff and facility closures, with particularly acute consequences in rural and underserved communities where PE-backed providers represent concentrated points of care access.
Sale-leaseback transactions—a core PE value-extraction mechanism—exemplify the tension between financial engineering and healthcare stability. Under this model, PE firms require portfolio companies to sell owned real estate assets and lease them back, converting fixed assets into recurring rent obligations. For healthcare operations already vulnerable to revenue volatility, this approach intensifies financial pressure and frequently necessitates staff reductions. Michael Goldhaber, senior research scholar leading NYU Stern's values-based investing program, emphasized the clinical stakes: "In the healthcare sector, slashing staff can be fatal. It can be a killer, simple as that."
The report advocates for reforms to PE investing practices rather than sector elimination, acknowledging that private equity provides both capital and operational expertise to healthcare. The emphasis falls on regulatory governance—establishing guardrails around leverage ratios, transaction structures, and staffing policies—to preserve the capital-provision benefits of PE while mitigating the care-quality deterioration and financial instability endemic to current leverage-maximization practices.
The scale of PE capital deployment in healthcare underscores the sector's systemic exposure. Private equity firms have invested over $1 trillion through debt-financed deals in the past decade alone, positioning PE as a material force across hospital networks, physician practices, and ancillary healthcare services. However, the financing structures underlying these transactions create acute vulnerabilities. PE-backed healthcare companies carry average debt-to-cash flow ratios of 7.1—well above the 4.0 threshold financial regulators designate as problematic—compared to 3.0 for publicly traded healthcare companies. This leverage differential directly constrains operational flexibility during economic downturns or unexpected cost pressures.
Bankruptcy rates underscore the financial fragility these structures create. Between 2023 and mid-2024, 26 large PE-backed healthcare firms filed for bankruptcy; including smaller portfolio companies, the total reached 34 healthcare bankruptcies in 2023. These failures often trigger cascading reductions in clinical staff and facility closures, with particularly acute consequences in rural and underserved communities where PE-backed providers represent concentrated points of care access.
Sale-leaseback transactions—a core PE value-extraction mechanism—exemplify the tension between financial engineering and healthcare stability. Under this model, PE firms require portfolio companies to sell owned real estate assets and lease them back, converting fixed assets into recurring rent obligations. For healthcare operations already vulnerable to revenue volatility, this approach intensifies financial pressure and frequently necessitates staff reductions. Michael Goldhaber, senior research scholar leading NYU Stern's values-based investing program, emphasized the clinical stakes: "In the healthcare sector, slashing staff can be fatal. It can be a killer, simple as that."
The report advocates for reforms to PE investing practices rather than sector elimination, acknowledging that private equity provides both capital and operational expertise to healthcare. The emphasis falls on regulatory governance—establishing guardrails around leverage ratios, transaction structures, and staffing policies—to preserve the capital-provision benefits of PE while mitigating the care-quality deterioration and financial instability endemic to current leverage-maximization practices.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.